Market Place
Sourcing Support
Charles River Strikes Deal with Gazi for Manufacturing
21 Jan 2026 //
BUSINESSWIRE
Charles River Expands Advanced Therapy Incubator Program Cohort
11 Dec 2025 //
PHARMIWEB
Charles River, X-Chem Partner To Boost Hit Identification
20 Oct 2025 //
PHARMIWEB
Charles River Joins EASYGEN for Bedside CAR-T Manufacturing
26 Aug 2025 //
BUSINESSWIRE
Myrtelle, Charles River, Viralgen Team on Canavan Therapy
09 Jul 2025 //
PR NEWSWIRE
Charles River, CHDI Extend Collaboration on Huntington`s Disease
29 May 2025 //
BUSINESSWIRE
Promega HiBiT-PsVLP Bioassay to Aid Global Vaccine Research
15 Apr 2025 //
BUSINESSWIRE
Pfizer, Flagship turn to autoimmune for latest angle of collab
02 Apr 2025 //
FIERCE PHARMA
FairJourney Acquires Charles River’s South San Francisco Facility
04 Mar 2025 //
BUSINESSWIRE
Charles River & Akron Integrate CGMP Materials Into Cell Therapy
16 Jan 2025 //
BUSINESSWIRE
Charles River expands biotech incubator to discovery stage
07 Dec 2024 //
FIERCE BIOTECH
Charles River Introduces Global Biotech Incubator Program
05 Dec 2024 //
BUSINESSWIRE
NJ Bio & Charles River Form ADC Development Alliance
05 Nov 2024 //
BUSINESSWIRE
FibroBiologics, Charles River Collaborate on Cell Therapies
18 Oct 2024 //
GLOBENEWSWIRE
Ori Biotech And Charles River Partner For Cell Therapies
18 Sep 2024 //
GLOBENEWSWIRE
Ori Enhances Charles River Collaboration With Cell Therapy Platform Data
18 Sep 2024 //
FIERCE PHARMA
Charles River And Captain T Cell Form Alliance For Gene-Modified Cell Therapy
17 Jun 2024 //
BUSINESSWIRE
Charles River, Captain T Cell Sign Plasmid DNA & Viral Vector Deal
17 Jun 2024 //
CONTRACT PHARMA
Charles River Laboratories to Present at William Blair and Jefferies Conferences
03 Jun 2024 //
BUSINESSWIRE
Charles River Safeguards Gene Therapy With Viral Vector Program
30 May 2024 //
BUSINESSWIRE
Charles River & Axovia Partner to Support Gene Therapies for Ciliopathies
09 Apr 2024 //
CONTRACTPHARMA
Charles River and Navega Announce Gene Therapy Manufacturing Collaboration
14 Mar 2024 //
BUSINESSWIRE
Charles River hits milestone on quest to manufacture Casgevy
18 Dec 2023 //
FIERCE PHARMA
Charles River and Genetic Cures Announce Gene Therapy Collaboration
28 Nov 2023 //
BUSINESSWIRE
Charles River Unveils Platform to Expedite Gene Therapy Manufacturing
26 Sep 2023 //
BUSINESSWIRE
Charles River Lab Launches Off-the-Shelf Lentiviral Vector Packaging Plasmids
13 Jun 2023 //
BUSINESSWIRE
Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy
12 Jun 2023 //
BUSINESSWIRE
Charles River Laboratories to Present at William Blair and Jefferies Conferences
05 Jun 2023 //
BUSINESSWIRE
Charles River Laboratories and Wheeler Bio Announce Agreement
31 May 2023 //
BUSINESSWIRE
Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study
30 May 2023 //
GLOBENEWSWIRE
Charles River Lab Showcases End-to-End Oncology Capabilities at AACR 2023
10 Apr 2023 //
BUSINESSWIRE
Charles River Launches pHelper Offering for AAV-based Gene Therapies
09 Mar 2023 //
CONTRACT PHARMA
Charles River & Purespring Announce Gene Therapy Manufacturing Collaboration
16 Feb 2023 //
BUSINESSWIRE
Charles River & Rznomics Announce Anticancer Gene Therapy Manufacturing Alliance
18 Jan 2023 //
BUSINESSWIRE
Charles River Establishes eXpDNA Plasmid Manufacturing Platform
12 Jan 2023 //
BUSINESSWIRE
